| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 12.1 | 12.8 | 11.2 |
| Other income | 0.0 | 0.1 | 0.0 |
| Total income | 12.1 | 12.9 | 11.2 |
| Profit before exceptional items & tax | 0.6 | 1.1 | 0.6 |
| Profit before tax | 0.6 | 1.1 | 0.6 |
| Net profit | 0.6 | 1.0 | 0.4 |
| Operating margin | 5.0% | 8.5% | 5.4% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +50.00% |
|---|---|
| Net profit, quarter on quarter | -40.00% |
| Revenue, year on year | +8.00% |
| Operating profit, quarter on quarter | -40.00% |
BSE results filing, NSE: CHOKSILA. Figures extracted from the filing.
Choksi Laboratories Ltd: key numbers
- Share price
- ₹190.05
- Market cap
- ₹132.4 Cr
- Revenue (annual)
- ₹46.01 Cr
- Net profit (annual)
- ₹1.96 Cr
- P/E (TTM)
- 61.2×Sector 57.8×
- Promoter holding
- 31.48%+0.00% QoQ
- FII holding
- 7.02%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Choksi Laboratories Ltd
All →Choksi Laboratories Annual General Meeting
Choksi Laboratories Ltd has scheduled an EGM for October 17, 2026, to seek shareholder approval for issuing 3.50 lakh convertible warrants at ₹177 per warrant.
- Value
- ₹6.20 Cr
Choksi Laboratories Capital Structure Change
Choksi Laboratories board approved a preferential issue of 3.5 lakh warrants to promoters at Rs 177 per warrant, totaling Rs 6.195 Crore.
- Value
- ₹6.20 Cr
Choksi Laboratories Annual General Meeting
Choksi Laboratories filed proceedings of its 33rd AGM held on 18 September 2026. Directors Sunil Choksi and Himika Choksi were re-appointed as Whole-Time Directors.
Choksi Laboratories Board Meeting Date
Choksi Laboratories announced a Board meeting on September 19, 2026, to discuss a proposal for raising funds through equity or convertible securities.
Choksi Laboratories Q4 FY26 Results: Net Profit ₹1 Cr, Up 11.1% YoY
Choksi Laboratories Ltd reported revenue from operations of ₹12.8 Cr (+12.3% YoY) and net profit of ₹1 Cr (+11.1% YoY) for Q4 FY26.
- Key figure
- Net profit ₹1 Cr · +11.1% YoY